These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31705717)

  • 41. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid-induced constipation in chronic pain: Experience with 180 patients.
    Velázquez Rivera I; Velázquez Clavarana L; García Velasco P; Melero Ramos C
    J Opioid Manag; 2019; 15(1):69-76. PubMed ID: 30855724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies.
    Merchant S; Provenzano D; Mody S; Ho KF; Etropolski M
    J Opioid Manag; 2013; 9(1):51-61. PubMed ID: 23709304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies.
    Lange B; von Zabern D; Elling C; Dubois C
    Curr Med Res Opin; 2017 Aug; 33(8):1413-1422. PubMed ID: 28537506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry.
    Überall MA; Elling C; Eibl C; Müller-Schwefe GH; Lefeber C; Heine M; Heckes B
    Pain Manag; 2022 Mar; 12(2):211-227. PubMed ID: 34376059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.
    Baron R; Jansen JP; Binder A; Pombo-Suarez M; Kennes L; Müller M; Falke D; Steigerwald I
    Pain Pract; 2016 Jun; 16(5):600-19. PubMed ID: 26554630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: a Systematic Review.
    Erosa SC; Haffey PR; Mehta N; Gulati A
    Curr Pain Headache Rep; 2021 Feb; 25(3):18. PubMed ID: 33630185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
    Etropolski M; Kuperwasser B; Flügel M; Häufel T; Lange B; Rauschkolb C; Laschewski F
    Adv Ther; 2014 Jun; 31(6):604-20. PubMed ID: 24985410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-relevant outcomes and health-related quality of life in patients with chronic, severe, noncancer pain treated with tapentadol prolonged release-Using criteria of health technology assessment.
    Hofmann JF; Lal A; Steffens M; Boettger R
    J Opioid Manag; 2016; 12(5):323-331. PubMed ID: 27844472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain.
    Coluzzi F; Ruggeri M
    Curr Med Res Opin; 2014 Jun; 30(6):1139-51. PubMed ID: 24528146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.
    Furlan AD; Sandoval JA; Mailis-Gagnon A; Tunks E
    CMAJ; 2006 May; 174(11):1589-94. PubMed ID: 16717269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.
    Watson CP; Babul N
    Neurology; 1998 Jun; 50(6):1837-41. PubMed ID: 9633737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tapentadol extended release for chronic pain patients.
    Taylor R; Pergolizzi JV; Raffa RB
    Adv Ther; 2013 Jan; 30(1):14-27. PubMed ID: 23328938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral or transdermal opioids for osteoarthritis of the knee or hip.
    Nüesch E; Rutjes AW; Husni E; Welch V; Jüni P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003115. PubMed ID: 19821302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials.
    Freynhagen R; Elling C; Radic T; Sohns M; Liedgens H; James D; McCool R; Edwards M
    Curr Med Res Opin; 2021 Jan; 37(1):89-100. PubMed ID: 33032466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.
    Weibel S; Jelting Y; Afshari A; Pace NL; Eberhart LH; Jokinen J; Artmann T; Kranke P
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011989. PubMed ID: 28407220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venlafaxine for neuropathic pain in adults.
    Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketamine as an adjuvant to opioids for cancer pain.
    Bell RF; Eccleston C; Kalso EA
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003351. PubMed ID: 28657160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.